• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺素H合酶对致癌马兜铃酸进行还原激活的证据——DNA加合物形成的(32)P后标记分析

Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.

作者信息

Stiborová M, Frei E, Breuer A, Wiessler M, Schmeiser H H

机构信息

Faculty of Science, Department of Biochemistry, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic.

出版信息

Mutat Res. 2001 Jun 27;493(1-2):149-60. doi: 10.1016/s1383-5718(01)00171-1.

DOI:10.1016/s1383-5718(01)00171-1
PMID:11516724
Abstract

Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, is implicated in an unique type of renal fibrosis, designated Chinese herbs nephropathy (CHN), which can develop to urothelial cancer. Understanding which enzymes are involved in AA activation and/or detoxication is important in the assessment of an individual susceptibility to this natural carcinogen. We examined the ability of prostaglandin H synthase (PHS) to activate AA to metabolites forming DNA adducts with the nuclease P1 and 1-butanol extraction enrichment procedure of the (32)P-postlabeling assay. PHS is a prominent enzyme in the kidney and urothelial tissues. Ram seminal vesicle (RSV) microsomes, which contain high levels of PHS, generated AA-DNA adduct patterns reproducing those found in renal tissues in CHN patients. 7-(Deoxyadenosin-N(6)-yl)aristolactam I, 7-(deoxyguanosin-N(2)-yl)aristolactam I and 7-(deoxyadenosin-N(6)-yl)aristolactam II were identified as AA-DNA adducts formed by AAI. Two adducts, 7-(deoxyguanosin-N(2)-yl)aristolactam II and 7-(deoxyadenosin-N(6)-yl)aristolactam II, were generated from AAII. According to the structures of the DNA adducts identified, nitroreduction is the crucial pathway in the metabolic activation of AA. The identity of PHS as the activating enzyme in RSV microsomes was proven with different cofactors and inhibitors. Only indomethacin, a selective inhibitor of PHS, significantly decreased the amount of adducts formed by RSV microsomes. The inhibitor of NADPH:CYP reductase (alpha-lipoic acid) and some selective inhibitors of cytochromes P450 (CYP) were not effective. Likewise, only cofactors of PHS, arachidonic acid and hydrogen peroxide, supported the DNA adduct formation of AAI and AAII, while NADPH and NADH were ineffective. These results demonstrate a key role of PHS in the activation pathway of AAI and AAII in the RSV microsomal system and were corroborated with the purified enzyme, namely ovine PHS-1. The results presented here are the first report demonstrating a reductive activation of nitroaromatic compounds by PHS-1.

摘要

马兜铃酸(AA)是一种天然存在的肾毒素和致癌物,与一种独特类型的肾纤维化有关,这种肾纤维化被称为中草药肾病(CHN),可发展为尿路上皮癌。了解哪些酶参与AA的激活和/或解毒对于评估个体对这种天然致癌物的易感性很重要。我们使用核酸酶P1和(32)P后标记分析的1-丁醇萃取富集程序,研究了前列腺素H合酶(PHS)将AA激活为形成DNA加合物的代谢物的能力。PHS是肾脏和尿路上皮组织中的一种重要酶。含有高水平PHS的公羊精囊(RSV)微粒体产生的AA-DNA加合物模式与CHN患者肾组织中发现的模式一致。7-(脱氧腺苷-N(6)-基)马兜铃内酰胺I、7-(脱氧鸟苷-N(2)-基)马兜铃内酰胺I和7-(脱氧腺苷-N(6)-基)马兜铃内酰胺II被鉴定为AAI形成的AA-DNA加合物。两种加合物,7-(脱氧鸟苷-N(2)-基)马兜铃内酰胺II和7-(脱氧腺苷-N(6)-基)马兜铃内酰胺II,由AAII产生。根据鉴定出的DNA加合物的结构,硝基还原是AA代谢激活的关键途径。通过不同的辅因子和抑制剂证明了PHS作为RSV微粒体中激活酶的身份。只有吲哚美辛,一种PHS的选择性抑制剂,显著降低了RSV微粒体形成的加合物的量。NADPH:CYP还原酶的抑制剂(α-硫辛酸)和一些细胞色素P450(CYP)的选择性抑制剂无效。同样,只有PHS的辅因子花生四烯酸和过氧化氢支持AAI和AAII的DNA加合物形成,而NADPH和NADH无效。这些结果证明了PHS在RSV微粒体系统中AAI和AAII激活途径中的关键作用,并且用纯化的酶,即绵羊PHS-1得到了证实。这里呈现的结果是首次报道证明PHS-1对硝基芳香化合物的还原激活作用。

相似文献

1
Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.前列腺素H合酶对致癌马兜铃酸进行还原激活的证据——DNA加合物形成的(32)P后标记分析
Mutat Res. 2001 Jun 27;493(1-2):149-60. doi: 10.1016/s1383-5718(01)00171-1.
2
Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.致癌和肾毒性生物碱马兜铃酸在被NADPH:细胞色素P450还原酶激活后,会形成在中草药肾病患者DNA中发现的加合物。
Gen Physiol Biophys. 2001 Dec;20(4):375-92.
3
Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.人肝微粒体、肾微粒体、细胞色素P450 1A1/2、NADPH:细胞色素P450还原酶和前列腺素H合酶介导了在尿路上皮癌患者中发现的马兜铃酸-DNA加合物的形成。
Int J Cancer. 2005 Jan 10;113(2):189-97. doi: 10.1002/ijc.20564.
4
Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.致癌的马兜铃酸经DT-黄递酶激活后形成加合物,这些加合物存在于中草药肾病患者的DNA中。
Carcinogenesis. 2002 Apr;23(4):617-25. doi: 10.1093/carcin/23.4.617.
5
Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.参与致癌马兜铃酸代谢活化的人体酶:细胞色素P450 1A1和1A2还原活化的证据。
Chem Res Toxicol. 2001 Aug;14(8):1128-37. doi: 10.1021/tx010059z.
6
32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.对服用含马兜铃酸的中药导致的中草药肾病患者组织中由马兜铃酸形成的DNA加合物进行32P后标记分析。
Carcinogenesis. 1997 May;18(5):1063-7. doi: 10.1093/carcin/18.5.1063.
7
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.参与致癌马兜铃酸代谢活化的人胞质酶:人NAD(P)H:醌氧化还原酶还原活化的证据。
Carcinogenesis. 2003 Oct;24(10):1695-703. doi: 10.1093/carcin/bgg119. Epub 2003 Jul 17.
8
Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.马兜铃酸 I 的代谢产物马兜铃内酰胺 I 经活化后形成一种加合物,在中草药肾病患者的 DNA 中可发现该加合物。
Exp Toxicol Pathol. 1999 Jul;51(4-5):421-7. doi: 10.1016/S0940-2993(99)80033-5.
9
Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.采用不同色谱方法,通过³²P后标记分析法对大鼠靶器官(前胃)中由马兜铃酸形成的DNA加合物进行表征。
Carcinogenesis. 1994 Jun;15(6):1187-92. doi: 10.1093/carcin/15.6.1187.
10
Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy.致癌性马兜铃酸的代谢活化,巴尔干地方性肾病的一个风险因素。
Mutat Res. 2008 Jan-Feb;658(1-2):55-67. doi: 10.1016/j.mrrev.2007.07.003. Epub 2007 Aug 6.

引用本文的文献

1
Absorptivity Is an Important Determinant in the Toxicity Difference between Aristolochic Acid I and Aristolochic Acid II.吸收系数是马兜铃酸I和马兜铃酸II毒性差异的重要决定因素。
J Agric Food Chem. 2025 Jan 29;73(4):2551-2561. doi: 10.1021/acs.jafc.4c10765. Epub 2025 Jan 14.
2
Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers.马兜铃酸突变特征在口腔-胃肠道癌症中的罕见发生
Cancers (Basel). 2022 Jan 24;14(3):576. doi: 10.3390/cancers14030576.
3
Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
马兜铃酸 I 和 II 的共同暴露会增加导致大鼠马兜铃酸 I 致癌性的 DNA 加合物的形成。
Int J Mol Sci. 2021 Sep 28;22(19):10479. doi: 10.3390/ijms221910479.
4
Nephrotoxicity of Herbal Medicine and Its Prevention.草药的肾毒性及其预防
Front Pharmacol. 2020 Oct 15;11:569551. doi: 10.3389/fphar.2020.569551. eCollection 2020.
5
Phytochemical Analysis and Toxicity Study of Rhizomes Decoction Used in Moroccan Alternative Medicine: Histopathological and Biochemical Profiles.摩洛哥替代医学中根茎煎剂的植物化学分析与毒性研究:组织病理学和生化特征
Evid Based Complement Alternat Med. 2019 Jul 3;2019:1398404. doi: 10.1155/2019/1398404. eCollection 2019.
6
Comparison of the oxidation of carcinogenic aristolochic acid I and II by microsomal cytochromes P450 in vitro: experimental and theoretical approaches.体外微粒体细胞色素P450对致癌性马兜铃酸I和II的氧化作用比较:实验和理论方法
Monatsh Chem. 2017;148(11):1971-1981. doi: 10.1007/s00706-017-2014-9. Epub 2017 Jul 26.
7
DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.马兜铃酸形成的 DNA 加合物是暴露的独特生物标志物,并解释了上尿路上皮癌的起始阶段。
Int J Mol Sci. 2017 Oct 14;18(10):2144. doi: 10.3390/ijms18102144.
8
Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse.影响小鼠马兜铃酸肾病毒性的遗传位点。
Am J Physiol Renal Physiol. 2011 Jun;300(6):F1360-7. doi: 10.1152/ajprenal.00716.2010. Epub 2011 Mar 23.
9
Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers.生物转化酶在马兜铃酸所致肾损伤和尿路上皮癌发生发展中的作用:紧迫的问题,艰难的答案。
Interdiscip Toxicol. 2008 Jun;1(1):8-12. doi: 10.2478/v10102-010-0023-1.
10
Biological reactive intermediates (BRIs) formed from botanical dietary supplements.植物性膳食补充剂产生的生物反应中间体(BRIs)。
Chem Biol Interact. 2011 Jun 30;192(1-2):72-80. doi: 10.1016/j.cbi.2010.10.007. Epub 2010 Oct 21.